199 related articles for article (PubMed ID: 36523163)
41. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
[TBL] [Abstract][Full Text] [Related]
42. Pluripotency-independent induction of human trophoblast stem cells from fibroblasts.
Naama M; Rahamim M; Zayat V; Sebban S; Radwan A; Orzech D; Lasry R; Ifrah A; Jaber M; Sabag O; Yassen H; Khatib A; Epsztejn-Litman S; Novoselsky-Persky M; Makedonski K; Deri N; Goldman-Wohl D; Cedar H; Yagel S; Eiges R; Buganim Y
Nat Commun; 2023 Jun; 14(1):3359. PubMed ID: 37291192
[TBL] [Abstract][Full Text] [Related]
43. Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.
Hawkins KE; Moschidou D; Faccenda D; Wruck W; Martin-Trujillo A; Hau KL; Ranzoni AM; Sanchez-Freire V; Tommasini F; Eaton S; De Coppi P; Monk D; Campanella M; Thrasher AJ; Adjaye J; Guillot PV
Mol Ther; 2017 Feb; 25(2):427-442. PubMed ID: 28153093
[TBL] [Abstract][Full Text] [Related]
44. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
45. Rad50 mediates DNA demethylation to establish pluripotent reprogramming.
Park H; Cho B; Kim J
Exp Mol Med; 2020 Jul; 52(7):1116-1127. PubMed ID: 32665583
[TBL] [Abstract][Full Text] [Related]
46. The roles of long noncoding RNAs in the regulation of OCT4 expression.
Zhou RT; Ni YR; Zeng FJ
Stem Cell Res Ther; 2022 Jul; 13(1):383. PubMed ID: 35907897
[TBL] [Abstract][Full Text] [Related]
47. Sphere formation permits Oct4 reprogramming of ciliary body epithelial cells into induced pluripotent stem cells.
Ni A; Wu MJ; Chavala SH
Stem Cells Dev; 2014 Dec; 23(24):3065-71. PubMed ID: 25027059
[TBL] [Abstract][Full Text] [Related]
48. Long noncoding RNA CCDC144NL-AS1 knockdown induces naïve-like state conversion of human pluripotent stem cells.
Wang Y; Guo B; Xiao Z; Lin H; Zhang X; Song Y; Li Y; Gao X; Yu J; Shao Z; Li X; Luo Y; Li S
Stem Cell Res Ther; 2019 Jul; 10(1):220. PubMed ID: 31358062
[TBL] [Abstract][Full Text] [Related]
49. Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition.
Li S; Xiao F; Zhang J; Sun X; Wang H; Zeng Y; Hu J; Tang F; Gu J; Zhao Y; Jin Y; Liao B
Stem Cell Reports; 2018 Oct; 11(4):973-987. PubMed ID: 30269953
[TBL] [Abstract][Full Text] [Related]
50. Deterministic Somatic Cell Reprogramming Involves Continuous Transcriptional Changes Governed by Myc and Epigenetic-Driven Modules.
Zviran A; Mor N; Rais Y; Gingold H; Peles S; Chomsky E; Viukov S; Buenrostro JD; Scognamiglio R; Weinberger L; Manor YS; Krupalnik V; Zerbib M; Hezroni H; Jaitin DA; Larastiaso D; Gilad S; Benjamin S; Gafni O; Mousa A; Ayyash M; Sheban D; Bayerl J; Aguilera-Castrejon A; Massarwa R; Maza I; Hanna S; Stelzer Y; Ulitsky I; Greenleaf WJ; Tanay A; Trumpp A; Amit I; Pilpel Y; Novershtern N; Hanna JH
Cell Stem Cell; 2019 Feb; 24(2):328-341.e9. PubMed ID: 30554962
[TBL] [Abstract][Full Text] [Related]
51. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
[TBL] [Abstract][Full Text] [Related]
52. Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming.
Kim DH; Marinov GK; Pepke S; Singer ZS; He P; Williams B; Schroth GP; Elowitz MB; Wold BJ
Cell Stem Cell; 2015 Jan; 16(1):88-101. PubMed ID: 25575081
[TBL] [Abstract][Full Text] [Related]
53. ALKBH5 regulates somatic cell reprogramming in a phase-specific manner.
Khodeer S; Klungland A; Dahl JA
J Cell Sci; 2022 Jun; 135(11):. PubMed ID: 35552718
[TBL] [Abstract][Full Text] [Related]
54. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming.
Gao Y; Chen J; Li K; Wu T; Huang B; Liu W; Kou X; Zhang Y; Huang H; Jiang Y; Yao C; Liu X; Lu Z; Xu Z; Kang L; Chen J; Wang H; Cai T; Gao S
Cell Stem Cell; 2013 Apr; 12(4):453-69. PubMed ID: 23499384
[TBL] [Abstract][Full Text] [Related]
55. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity.
Chia NY; Chan YS; Feng B; Lu X; Orlov YL; Moreau D; Kumar P; Yang L; Jiang J; Lau MS; Huss M; Soh BS; Kraus P; Li P; Lufkin T; Lim B; Clarke ND; Bard F; Ng HH
Nature; 2010 Nov; 468(7321):316-20. PubMed ID: 20953172
[TBL] [Abstract][Full Text] [Related]
56. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
57. Human Ocular Epithelial Cells Endogenously Expressing SOX2 and OCT4 Yield High Efficiency of Pluripotency Reprogramming.
Poon MW; He J; Fang X; Zhang Z; Wang W; Wang J; Qiu F; Tse HF; Li W; Liu Z; Lian Q
PLoS One; 2015; 10(7):e0131288. PubMed ID: 26131692
[TBL] [Abstract][Full Text] [Related]
58. Chromatin Accessibility Dynamics during iPSC Reprogramming.
Li D; Liu J; Yang X; Zhou C; Guo J; Wu C; Qin Y; Guo L; He J; Yu S; Liu H; Wang X; Wu F; Kuang J; Hutchins AP; Chen J; Pei D
Cell Stem Cell; 2017 Dec; 21(6):819-833.e6. PubMed ID: 29220666
[TBL] [Abstract][Full Text] [Related]
59. Profiling mitochondria-polyribosome lncRNAs associated with pluripotency.
Zhou L; Li H; Sun T; Wen X; Niu C; Li M; Li W; Esteban MA; Hoffman AR; Hu JF; Cui J
Sci Data; 2023 Nov; 10(1):755. PubMed ID: 37919270
[TBL] [Abstract][Full Text] [Related]
60. High throughput sequencing identifies an imprinted gene, Grb10, associated with the pluripotency state in nuclear transfer embryonic stem cells.
Li H; Gao S; Huang H; Liu W; Huang H; Liu X; Gao Y; Le R; Kou X; Zhao Y; Kou Z; Li J; Wang H; Zhang Y; Wang H; Cai T; Sun Q; Gao S; Han Z
Oncotarget; 2017 Jul; 8(29):47344-47355. PubMed ID: 28476045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
